About Our Experimental Anaplasmosis Vaccine

We are pleased to provide information about our experimental anaplasmosis vaccine, which is available to veterinarians in select states that have received experimental approval from the USDA. This innovative vaccine is produced at the Louisiana State University AgCenter Facility located in Baton Rouge, Louisiana.

Since its launch in May 2000, our vaccine has been successfully sold in many states, including Puerto Rico. Contact us to learn more about our vaccine. We are happy to discuss the vaccine and provide further information to assist you.

Theileria orientalis Ikeda
Information from USDA, Emerging Risk Notice

• Theileria orientalis is a tick-borne protozoan that infects red and white blood cells and causes bovine infectious anemia. Clinical signs of theileriosis are similar to anaplasmosis in cattle and include anemia, jaundice, and weakness. Native genotypes of T. orientalis in the United States are usually nonpathogenic; however, the virulent Theileria orientalis Ikeda genotype has been identified in the United States.

As of May 2024, ALHT has been identified in 20 states: Arkansas, Connecticut, Delaware, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, and West Virginia. The USDA maintains a publicly accessible website that provides information on ALHT and maps showing the current distribution of ticks in the U.S.